What do systematic reviews say?

Pain · people with dermatomyositis and polymyositis

Pain · boys with DMD

Pain · people with mitochondrial myopathy

Pain · people with myotonic dystrophy type 1

Pain · people with myotonic dystrophy

Pain · people with dermatomyositis and polymyositis

Pain · people with facioscapulohumeral muscular dystrophy

Pain · children with ITW gait

Pain at 6 months or more · the treatment of diabetic peripheral neuropathy

Pain ‐ Long‐term improvement: > 3 months · carpal tunnel syndrome

Pain at short term (4 weeks) VAS 10‐cm scale, which was translated to a 0 to 100 scale in which lower scores mean less pain. · Morton's neuroma

Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale)

Change in nerve pain and in nerve tenderness at 1 year ‐ not reported · people with nerve damage (6 to 24 months' duration) in leprosy

Change in nerve pain and in nerve tenderness at 1 year ‐ not reported · people with nerve damage (< 6 months' duration) in leprosy

Reduction in pain intensity · patients with trigeminal neuralgia

Reduction in pain intensity · patients with trigeminal neuralgia

Reduction in pain intensity · patients with trigeminal neuralgia

Participant‐reported pain relief of 50% or greater · patients with pain in Guillain‐Barré syndrome

Participant‐reported pain relief of 50% or greater · patients with pain in Guillain‐Barré syndrome

Participant‐reported pain relief of 50% or greater · intensive care unit in India